Releasing agent: Difference between revisions
>Tracer Added Category:Pharmacology |
>David Hedlund {{#set:Featured=true}} |
||
(2 intermediate revisions by 2 users not shown) | |||
Line 6: | Line 6: | ||
==Selectivity== | ==Selectivity== | ||
Releasing agents act to varying extents on the monoamine neurotransmitters. Some will induce the release of all three monoamines; an example of this is [[MDMA]]. Others are more selective as [[methamphetamine]] is a potent releasing agent of dopamine and noradrenaline, but is a weak releaser of serotonin. A majority of releasing agents are non-selective, but there are currently a limited amount of agents that release serotonin (SRAs) or norephinephrine (NRAs) selectively; no selective dopamine releasing agents are currently known. Many tryptamines, such as [[DMT]], [[DiPT]], and [[psilocin]], are selective serotonin releasing agents in addition to their other pharmacological effects.<ref>Blough | Releasing agents act to varying extents on the monoamine neurotransmitters. Some will induce the release of all three monoamines; an example of this is [[MDMA]]. Others are more selective as [[methamphetamine]] is a potent releasing agent of dopamine and noradrenaline, but is a weak releaser of serotonin. A majority of releasing agents are non-selective, but there are currently a limited amount of agents that release serotonin (SRAs) or norephinephrine (NRAs) selectively; no selective dopamine releasing agents are currently known. Many tryptamines, such as [[DMT]], [[DiPT]], and [[psilocin]], are selective serotonin releasing agents in addition to their other pharmacological effects.<ref>{{cite journal | vauthors=((Blough, B. E.)), ((Landavazo, A.)), ((Decker, A. M.)), ((Partilla, J. S.)), ((Baumann, M. H.)), ((Rothman, R. B.)) | journal=Psychopharmacology | title=Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes | volume=231 | issue=21 | pages=4135–4144 | date= October 2014 | issn=1432-2072 | doi=10.1007/s00213-014-3557-7}}</ref> | ||
==Neurotoxicity== | ==Neurotoxicity== | ||
Line 18: | Line 18: | ||
*[[Antagonist]] | *[[Antagonist]] | ||
*[[Reuptake inhibitor]] | *[[Reuptake inhibitor]] | ||
==External links== | |||
*[https://en.wikipedia.org/wiki/Release_agent Release agent (Wikipedia)] | |||
==References== | ==References== | ||
[[Category:Pharmacology]] | [[Category:Pharmacology]] | ||
{{#set:Featured=true}} |